{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:37:23Z","timestamp":1770417443779,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/81598\/2011"],"award-info":[{"award-number":["SFRH\/BD\/81598\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/72523\/2010"],"award-info":[{"award-number":["SFRH\/BPD\/72523\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/79022\/2011"],"award-info":[{"award-number":["SFRH\/BD\/79022\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BTM-SAL\/30577\/2017"],"award-info":[{"award-number":["PTDC\/BTM-SAL\/30577\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iNOVA4Health Research Unit","award":["LISBOA-01-0145-FEDER-007344"],"award-info":[{"award-number":["LISBOA-01-0145-FEDER-007344"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13568-019-0741-5","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T01:02:27Z","timestamp":1549501347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-5197","authenticated-orcid":false,"given":"Hugo R.","family":"Soares","sequence":"first","affiliation":[]},{"given":"Rute","family":"Castro","sequence":"additional","affiliation":[]},{"given":"H\u00e9lio A.","family":"Tom\u00e1s","sequence":"additional","affiliation":[]},{"given":"Manuel J. T.","family":"Carrondo","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ana S.","family":"Coroadinha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"741_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"036331000","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Dubuisson J, Cosset F-L (2003) Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes. J Exp Med J Exp Med 036331000:633\u2013642. \n                    https:\/\/doi.org\/10.1084\/jem.20021756","journal-title":"J Exp Med J Exp Med"},{"key":"741_CR2","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jhep.2014.09.009","volume":"61","author":"TF Baumert","year":"2014","unstructured":"Baumert TF, Fauvelle C, Chen DY, Lauer GM (2014) A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing. J Hepatol 61:S34\u2013S44. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2014.09.009","journal-title":"J Hepatol"},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/erv.13.10","volume":"12","author":"B Bellier","year":"2013","unstructured":"Bellier B, Klatzmann D (2013) Virus-like particle-based vaccines against hepatitis C virus infection. Expert Rev Vaccines 12:143\u2013154. \n                    https:\/\/doi.org\/10.1586\/erv.13.10","journal-title":"Expert Rev Vaccines"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.vaccine.2005.11.034","volume":"24","author":"B Bellier","year":"2006","unstructured":"Bellier B, Dalba C, Clerc B, Desjardins D, Drury R, Cosset F-L, Collins M, Klatzmann D (2006) DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine 24:2643\u20132655. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.034","journal-title":"Vaccine"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1016\/j.vaccine.2009.07.059","volume":"27","author":"B Bellier","year":"2009","unstructured":"Bellier B, Huret C, Miyalou M, Desjardins D, Frenkiel M-P, Despres P, Tangy F, Dalba C, Klatzmann D (2009) DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine 27:5772\u20135780. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.059","journal-title":"Vaccine"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jgm.1307","volume":"11","author":"D Desjardins","year":"2009","unstructured":"Desjardins D, Huret C, Dalba C, Kreppel F, Kochanek S, Cosset F-L, Tangy F, Klatzmann D, Bellier B (2009) Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. J Gene Med 11:313\u2013325. \n                    https:\/\/doi.org\/10.1002\/jgm.1307","journal-title":"J Gene Med"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"94ra71","DOI":"10.1126\/scitranslmed.3002330","volume":"3","author":"P Garrone","year":"2011","unstructured":"Garrone P, Fluckiger A-C, Mangeot PE, Gauthier E, Dupeyrot-Lacas P, Mancip J, Cangialosi A, Du Ch\u00e9n\u00e9 I, LeGrand R, Mangeot I, Lavillette D, Bellier B, Cosset F-L, Tangy F, Klatzmann D, Dalba C (2011) A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques. Sci Transl Med 3:94ra71. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3002330","journal-title":"Sci Transl Med"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molimm.2018.05.017","volume":"101","author":"P Gogesch","year":"2018","unstructured":"Gogesch P, Sch\u00fclke S, Scheurer S, M\u00fchlebach MD, Waibler Z (2018) Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b\u2009+\u2009APC and antigen-specific T cell responses in vitro. Mol Immunol 101:19\u201328. \n                    https:\/\/doi.org\/10.1016\/j.molimm.2018.05.017","journal-title":"Mol Immunol"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45\u2013S57. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2014.07.027","journal-title":"J Hepatol"},{"key":"741_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.vaccine.2012.05.025","volume":"31","author":"C Huret","year":"2013","unstructured":"Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadi\u00e8re B, Dalba C, Klatzmann D, Bellier B (2013) Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Vaccine 31:1540\u20131547. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.025","journal-title":"Vaccine"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1128\/CVI.00662-13","volume":"21","author":"M Kirchmeier","year":"2014","unstructured":"Kirchmeier M, Fluckiger A-C, Soare C, Bozic J, Ontsouka B, Ahmed T, Diress A, Pereira L, Schodel F, Plotkin S, Dalba C, Klatzmann D, Anderson DE (2014) Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin Vaccine Immunol 21:174\u2013180. \n                    https:\/\/doi.org\/10.1128\/CVI.00662-13","journal-title":"Clin Vaccine Immunol"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"201518934","DOI":"10.1073\/pnas.1518934113","volume":"113","author":"M Lussignol","year":"2016","unstructured":"Lussignol M, Kopp M, Molloy K, Vizcay-Barrena G, Fleck RA, Dorner M, Bell KL, Chait BT, Rice CM, Catanese MT (2016) Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis. Proc Natl Acad Sci 113:201518934. \n                    https:\/\/doi.org\/10.1073\/pnas.1518934113","journal-title":"Proc Natl Acad Sci"},{"key":"741_CR13","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/eji.200424887","volume":"34","author":"F Masciopinto","year":"2004","unstructured":"Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TSB, Houghton M, Pileri P, Abrignani S (2004) Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol 34:2834\u20132842. \n                    https:\/\/doi.org\/10.1002\/eji.200424887","journal-title":"Eur J Immunol"},{"key":"741_CR14","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1128\/JVI.78.6.2994","volume":"78","author":"A Op De Beeck","year":"2004","unstructured":"Op De Beeck A, Voisset C, Bartosch B, Ciczora Y, Cocquerel L, Keck Z, Foung S, Cosset F-L, Dubuisson J (2004) Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78:2994\u20133002. \n                    https:\/\/doi.org\/10.1128\/JVI.78.6.2994","journal-title":"J Virol"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01230-17","volume":"91","author":"F Pitoiset","year":"2017","unstructured":"Pitoiset F, Vazquez T, Levacher B, Nehar-Belaid D, D\u00e9rian N, Vigneron J, Klatzmann D, Bellier B (2017) Retrovirus-based virus-like particle immunogenicity and its modulation by Toll-Like Receptor activation. J Virol 91:1\u201314. \n                    https:\/\/doi.org\/10.1128\/JVI.01230-17","journal-title":"J Virol"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/bit.23231","volume":"108","author":"AF Rodrigues","year":"2011","unstructured":"Rodrigues AF, Guerreiro MR, Santiago VM, Dalba C, Klatzmann D, Alves PM, Carrondo MJT, Coroadinha AS (2011) Down-regulation of CD81 tetraspanin in human cells producing retroviral-based particles: tailoring vector composition. Biotechnol Bioeng 108:2623\u20132633. \n                    https:\/\/doi.org\/10.1002\/bit.23231","journal-title":"Biotechnol Bioeng"},{"key":"741_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/CVI.00194-12","volume":"19","author":"JE Roughan","year":"2012","unstructured":"Roughan JE, Reardon KM, Cogburn KE, Quendler H, Pockros PJ, Law M (2012) Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells. Clin Vaccine Immunol 19:1027\u20131037. \n                    https:\/\/doi.org\/10.1128\/CVI.00194-12","journal-title":"Clin Vaccine Immunol"},{"key":"741_CR18","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/JVI.01909-07","volume":"82","author":"MM Segura","year":"2008","unstructured":"Segura MM, Garnier A, Di Falco MR, Whissell G, Meneses-Acosta A, Arcand N, Kamen A (2008) Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J Virol 82:1107\u20131117. \n                    https:\/\/doi.org\/10.1128\/JVI.01909-07","journal-title":"J Virol"},{"key":"741_CR19","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.vaccine.2015.12.015","volume":"34","author":"HR Soares","year":"2016","unstructured":"Soares HR, Castro R, Tom\u00e1s HA, Rodrigues AF, Gomes-Alves P, Bellier B, Klatzmann D, Carrondo MJT, Alves PM, Coroadinha AS (2016) Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity. Vaccine 34:1634\u20131641. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.015","journal-title":"Vaccine"},{"key":"741_CR20","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1128\/JVI.02700-15","volume":"90","author":"RA Urbanowicz","year":"2015","unstructured":"Urbanowicz RA, McClure CP, Brown RJP, Tsoleridis T, Persson MAA, Krey T, Irving WL, Ball JK, Tarr AW (2015) A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance. J Virol 90:3288\u20133301. \n                    https:\/\/doi.org\/10.1128\/JVI.02700-15","journal-title":"J Virol"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-019-0741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13568-019-0741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-019-0741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:05:53Z","timestamp":1581015953000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-019-0741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s13568-019-0741-5","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}